Exchange: NASDAQ·Updated 07:48 PM EST

MRUS Merus N.V

$89.00
$6.92
(7.14%)
Today
Closed $90.00
$1.00
(1.11%)
After Hours
Reported EarningsAug 5
Mkt Cap$6.83B
Vol2.73M

About MRUS

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.
44

Bearish Sentiment

How do you feel about MRUS?

Advertisement|Remove ads.